LearnGlossaryMarketStocksSuperinvestorsSign in

CSSPF

NIOX Group Plc

Healthcare · $378M market cap

Verdict

Share price

$0.899

close of Oct 1, 2026

Fair value

$0.506

Sticker Price

Payback Price

$0.202

buy price

Overpriced

CSSPF is Overpriced: at $0.899 it trades 78% above its fair value of $0.506. Its buy price (Payback Price) is $0.202, 77% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.

How we valued it

Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth-9.0% a year✗
Equity per share growth-0.5% a year✗
Sales growth12.2% a year✓
Free cash flow growth38.2% a year✓
Return on invested capital6.9%✗

Follow CSSPF

Get notified when it reaches its buy price of $0.202. Free.

Create a free account

About NIOX Group Plc

Niox Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis and management of asthma. It offers NIOX VERO, a non-invasive point-of-care system that provides fractional exhaled nitric oxide (FeNO) measurements. The company was founded by Steven Harris and Charles Stuart Webb Swingland on May 19, 2006 and is headquartered in Oxford, the United Kingdom.

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 1, 2026. How the Payback Price works